Li, Boyu, et al. “Effects of Canagliflozin on Fatty Liver Indexes in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 21, no. 1, June 2018, pp. 222-35, doi:10.18433/jpps29831.